Grants

Grants reflect financial support to US-based organizations that foster increased understanding of scientific, clinical, and healthcare issues and contribute to improving patient care. This includes financial support through contributions, memberships and sponsorships.

Examples include:

Funding to patient advocacy organizations: Among the nonprofits we support are patient groups that provide patients, their families, and friends with support and information on how to live with a disease.

Funding to Healthcare Professional Associations (HPAs) – We support medical, disease-oriented, or scientific policy organizations that have a significant percentage of members who are healthcare professionals and that represent their interests by providing information and services, support for increased medical research, and/or access to healthcare but do not recommend medicines.

Funding to support third-party educational activities for healthcare professionals – In the US, we award grants to fund independent third-party educational activities for healthcare professionals that are clearly designed to close documented gaps in patient care. These activities are designed and implemented by third-party educational providers with no GSK control, influence or involvement. More information about our process is available on our website.

Community Partnership charitable grants are also provided based on community needs, independent from our therapeutic areas of interest. All requests are subject to the availability of funding. More information is available on our website.

GSK has criteria in place to govern the grant funding and approval process. Our policies prohibit offering funding in return for any prescribing, purchasing, or recommendations for our products. We also have processes in place and work diligently to help ensure that our support is in compliance with all applicable laws, rules and regulations, including the guidelines and standards set by the Office of Inspector General (OIG), the Accreditation Council for Continuing Medical Education (ACCME) and other national accrediting organizations, the American Medical Association, the US Food and Drug Administration (FDA), and the Pharmaceutical Research and Manufacturers of America Code.

In the event GSK has funded a grant to a CMS identified Teaching Hospital, the grant will be included in our submission of data to CMS. These grants are not part of the GSK posted Grants Report. 

We are committed to transparency in our work and committed to meeting all state and federal reporting requirements, including the Open Payments Report (commonly known as The Sunshine Act) as well as a Corporate Integrity Agreement (CIA) in which GSK entered in July 2012 with the Office of the Inspector General for the Department of Health and Human Services (HHS). Disclosure requirements in the CIA and the Open Payments Report are aligned.

GSK is committed to providing as complete and accurate a disclosure report as possible and has established internal processes to continually review and validate our accuracy and disclosures. If there are transactions that come to our attention that require adjustments and sufficient information is available, those adjustments may be applied directly through revision to this report or may be made in subsequent reporting periods. Questions about this report should be submitted to the GSK Response Center at 1-888-725-0016. Hours are Monday through Friday from 8:30 AM to 5:30 PM Eastern Time.